According to CRISPR Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$7.83 Million. In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of HK$0.27 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.